Bosnia and Herzegovina

Bosnia and Herzegovina

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.59 (0.52 - 0.66) 2019 Modelled IHME
0.61 (0.54 - 0.68) 2018 Modelled IHME
0.62 (0.55 - 0.70) 2017 Modelled IHME
0.61 (0.54 - 0.68) 2016 Modelled IHME
0.61 (0.53 - 0.68) 2015 Modelled IHME
0.61 (0.54 - 0.68) 2014 Modelled IHME
0.62 (0.54 - 0.68) 2013 Modelled IHME
0.63 (0.55 - 0.70) 2012 Modelled IHME
0.64 (0.56 - 0.71) 2011 Modelled IHME
0.64 (0.56 - 0.73) 2010 Modelled IHME
0.65 (0.57 - 0.74) 2009 Modelled IHME
0.67 (0.58 - 0.75) 2008 Modelled IHME
0.68 (0.59 - 0.77) 2007 Modelled IHME
0.69 (0.60 - 0.79) 2006 Modelled IHME
0.7 (0.60 - 0.80) 2005 Modelled IHME
0.7 (0.61 - 0.80) 2004 Modelled IHME
0.7 (0.61 - 0.80) 2003 Modelled IHME
0.7 (0.60 - 0.80) 2002 Modelled IHME
0.7 (0.60 - 0.80) 2001 Modelled IHME
0.71 (0.60 - 0.81) 2000 Modelled IHME
0.72 (0.61 - 0.82) 1999 Modelled IHME
0.74 (0.62 - 0.84) 1998 Modelled IHME
0.76 (0.64 - 0.87) 1997 Modelled IHME
0.78 (0.66 - 0.89) 1996 Modelled IHME
0.78 (0.67 - 0.90) 1995 Modelled IHME
0.78 (0.67 - 0.90) 1994 Modelled IHME
0.77 (0.66 - 0.89) 1993 Modelled IHME
0.76 (0.65 - 0.87) 1992 Modelled IHME
0.74 (0.63 - 0.85) 1991 Modelled IHME
0.71 (0.60 - 0.82) 1990 Modelled IHME
2.2 (0.23 - 14.61) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.08 (0.06 - 0.10) 2019 Modelled IHME
0.08 (0.06 - 0.11) 2018 Modelled IHME
0.08 (0.06 - 0.11) 2017 Modelled IHME
0.08 (0.05 - 0.10) 2016 Modelled IHME
0.07 (0.05 - 0.09) 2015 Modelled IHME
0.06 (0.04 - 0.08) 2014 Modelled IHME
0.06 (0.04 - 0.08) 2013 Modelled IHME
0.05 (0.04 - 0.07) 2012 Modelled IHME
0.05 (0.04 - 0.07) 2011 Modelled IHME
0.05 (0.04 - 0.07) 2010 Modelled IHME
0.05 (0.04 - 0.07) 2009 Modelled IHME
0.06 (0.04 - 0.08) 2008 Modelled IHME
0.06 (0.04 - 0.09) 2007 Modelled IHME
0.07 (0.05 - 0.10) 2006 Modelled IHME
0.08 (0.05 - 0.11) 2005 Modelled IHME
0.09 (0.06 - 0.13) 2004 Modelled IHME
0.11 (0.07 - 0.15) 2003 Modelled IHME
0.13 (0.08 - 0.17) 2002 Modelled IHME
0.15 (0.10 - 0.20) 2001 Modelled IHME
0.17 (0.11 - 0.23) 2000 Modelled IHME
0.21 (0.14 - 0.28) 1999 Modelled IHME
0.26 (0.18 - 0.35) 1998 Modelled IHME
0.31 (0.22 - 0.42) 1997 Modelled IHME
0.35 (0.25 - 0.48) 1996 Modelled IHME
0.37 (0.26 - 0.50) 1995 Modelled IHME
0.37 (0.26 - 0.50) 1994 Modelled IHME
0.37 (0.25 - 0.49) 1993 Modelled IHME
0.35 (0.25 - 0.47) 1992 Modelled IHME
0.33 (0.23 - 0.44) 1991 Modelled IHME
0.3 (0.21 - 0.40) 1990 Modelled IHME
0.3 (0.03 - 2.15) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
21 (14 - 29) 2019 Modelled IHME
21 (15 - 29) 2018 Modelled IHME
21 (15 - 29) 2017 Modelled IHME
21 (15 - 29) 2016 Modelled IHME
21 (15 - 29) 2015 Modelled IHME
22 (15 - 30) 2014 Modelled IHME
22 (16 - 30) 2013 Modelled IHME
22 (16 - 31) 2012 Modelled IHME
22 (16 - 31) 2011 Modelled IHME
23 (16 - 32) 2010 Modelled IHME
23 (16 - 33) 2009 Modelled IHME
24 (17 - 33) 2008 Modelled IHME
24 (17 - 34) 2007 Modelled IHME
25 (18 - 35) 2006 Modelled IHME
25 (18 - 35) 2005 Modelled IHME
26 (18 - 36) 2004 Modelled IHME
26 (18 - 36) 2003 Modelled IHME
27 (19 - 37) 2002 Modelled IHME
27 (19 - 38) 2001 Modelled IHME
28 (20 - 39) 2000 Modelled IHME
28 (20 - 39) 1999 Modelled IHME
29 (20 - 39) 1998 Modelled IHME
29 (20 - 40) 1997 Modelled IHME
29 (21 - 40) 1996 Modelled IHME
30 (21 - 40) 1995 Modelled IHME
30 (21 - 40) 1994 Modelled IHME
30 (21 - 40) 1993 Modelled IHME
30 (22 - 40) 1992 Modelled IHME
30 (22 - 40) 1991 Modelled IHME
30 (22 - 40) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
80 2018 Survey/reported WHO/UNICEF
77 2017 Survey/reported WHO/UNICEF
78 2016 Survey/reported WHO/UNICEF
82 2015 Survey/reported WHO/UNICEF
89 2014 Survey/reported WHO/UNICEF
91 2013 Survey/reported WHO/UNICEF
92 2012 Survey/reported WHO/UNICEF
88 2011 Survey/reported WHO/UNICEF
89 2010 Survey/reported WHO/UNICEF
90 2009 Survey/reported WHO/UNICEF
88 2008 Survey/reported WHO/UNICEF
94 2007 Survey/reported WHO/UNICEF
90 2006 Survey/reported WHO/UNICEF
93 2005 Survey/reported WHO/UNICEF
36 2004 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
HCV National Action Plan
HBV elimination goal
Eligible for HCV generic medicines
HCV testing policy
No
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.22 (1 - 1.52) 2019 Modelled IHME
1.22 (1 - 1.50) 2018 Modelled IHME
1.21 (0.98 - 1.48) 2017 Modelled IHME
1.2 (0.98 - 1.46) 2016 Modelled IHME
1.18 (0.97 - 1.47) 2015 Modelled IHME
1.18 (0.96 - 1.45) 2014 Modelled IHME
1.18 (0.96 - 1.44) 2013 Modelled IHME
1.18 (0.96 - 1.44) 2012 Modelled IHME
1.17 (0.95 - 1.43) 2011 Modelled IHME
1.17 (0.95 - 1.44) 2010 Modelled IHME
1.17 (0.94 - 1.43) 2009 Modelled IHME
1.16 (0.94 - 1.42) 2008 Modelled IHME
1.15 (0.92 - 1.41) 2007 Modelled IHME
1.14 (0.92 - 1.40) 2006 Modelled IHME
1.14 (0.91 - 1.39) 2005 Modelled IHME
1.13 (0.91 - 1.39) 2004 Modelled IHME
1.12 (0.90 - 1.38) 2003 Modelled IHME
1.12 (0.90 - 1.37) 2002 Modelled IHME
1.11 (0.90 - 1.37) 2001 Modelled IHME
1.11 (0.90 - 1.38) 2000 Modelled IHME
1.12 (0.90 - 1.38) 1999 Modelled IHME
1.14 (0.91 - 1.40) 1998 Modelled IHME
1.16 (0.93 - 1.42) 1997 Modelled IHME
1.18 (0.95 - 1.45) 1996 Modelled IHME
1.19 (0.95 - 1.46) 1995 Modelled IHME
1.19 (0.95 - 1.46) 1994 Modelled IHME
1.18 (0.95 - 1.45) 1993 Modelled IHME
1.17 (0.94 - 1.44) 1992 Modelled IHME
1.16 (0.93 - 1.43) 1991 Modelled IHME
1.14 (0.91 - 1.41) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
39.9 (27.50 - 52.40) 2014 Modelled Degenhardt L et al, 2017

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
31 (23 - 40) 2019 Modelled IHME
31 (23 - 41) 2018 Modelled IHME
31 (22 - 40) 2017 Modelled IHME
31 (23 - 40) 2016 Modelled IHME
31 (23 - 41) 2015 Modelled IHME
31 (23 - 41) 2014 Modelled IHME
31 (22 - 40) 2013 Modelled IHME
31 (22 - 40) 2012 Modelled IHME
31 (22 - 40) 2011 Modelled IHME
31 (22 - 40) 2010 Modelled IHME
31 (22 - 40) 2009 Modelled IHME
31 (22 - 40) 2008 Modelled IHME
30 (21 - 39) 2007 Modelled IHME
30 (21 - 39) 2006 Modelled IHME
30 (21 - 39) 2005 Modelled IHME
30 (21 - 39) 2004 Modelled IHME
29 (21 - 38) 2003 Modelled IHME
29 (20 - 38) 2002 Modelled IHME
28 (20 - 37) 2001 Modelled IHME
27 (19 - 36) 2000 Modelled IHME
27 (19 - 36) 1999 Modelled IHME
27 (19 - 36) 1998 Modelled IHME
27 (19 - 36) 1997 Modelled IHME
27 (18 - 36) 1996 Modelled IHME
27 (19 - 36) 1995 Modelled IHME
27 (19 - 36) 1994 Modelled IHME
27 (18 - 36) 1993 Modelled IHME
27 (19 - 36) 1992 Modelled IHME
27 (18 - 36) 1991 Modelled IHME
27 (18 - 36) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
Eligible for HBV generic medicines
HCV National Action Plan
HBV elimination goal
Eligible for HCV generic medicines
HCV testing policy
No
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
Yes
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)

Overview

HBV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.59 (%)
2019
(0.52 - 0.66(%))
IHME
HCV (RNA/cAg+)
1.22 (%)
2019
(1 - 1.52(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
210
2019
(148 - 284)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
262
2019
(185 - 353)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.08 (%)
2019, latest modelled
(0.06 - 0.10(%))
IHME

Prevalence PWID

HCV
39.90 (%)
2014, latest modelled
(27.50 - 52.40(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines